Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Publications

Optimising Multi-stakeholder Practices in Patient Engagement: A Gap Analysis to Enable Focused Evolution of Patient Engagement in the Development and Lifecycle Management of Medicines.

Faulkner SD. et al, (2021), Ther Innov Regul Sci

Sustaining Meaningful Patient Engagement Across the Lifecycle of Medicines: A Roadmap for Action

Cavaller-Bellaubi M. et al, (2021), Therapeutic Innovation & Regulatory Science

Understanding multi-stakeholder needs, preferences and expectations to define effective practices and processes of patient engagement in medicine development: A mixed-methods study

Faulkner SD. et al, (2021), Health Expectations

Medicines Adaptive Pathways to Patients: Why, When, and How to Engage?

Le Cam Y. et al, (2018), Clinical Pharmacology and Therapeutics

Maximising value from a United Kingdom Biomedical Research Centre: study protocol

Greenhalgh T. et al, (2017), Health research policy and systems, 15

An assessment of implications of adaptive licensing for pharmaceutical intellectual property and regulatory exclusivity rights in the European Union

(2016), Clinical Pharmacology and Therapeutics, 100, 743 - 753

Pricing and reimbursement experiences and insights in the European Union and the United States: Lessons learned to approach adaptive payer pathways

Pani L. and Barker R., (2016), Clinical Pharmacology and Therapeutics, 100, 730 - 742

Brain mitochondrial oxidative metabolism during and after cerebral hypoxia-ischemia studied by simultaneous phosphorus magnetic-resonance and broadband near-infrared spectroscopy.

Bainbridge A. et al, (2014), Neuroimage, 102 Pt 1, 173 - 183